Ericson, M. D., Shaikh, R., Larson, C. M., Freeman, K. T., & Haskell-Luevano, C. (2020). Multiresidue Tetrapeptide Substitutions Yield a 140-fold Selective Melanocortin-3 over Melanocortin-4 Receptor Agonist. ACS Med Chem Lett.
Style de citation ChicagoEricson, Mark D., Romessa Shaikh, Courtney M. Larson, Katie T. Freeman, et Carrie Haskell-Luevano. "Multiresidue Tetrapeptide Substitutions Yield a 140-fold Selective Melanocortin-3 Over Melanocortin-4 Receptor Agonist." ACS Med Chem Lett 2020.
Style de citation MLAEricson, Mark D., et al. "Multiresidue Tetrapeptide Substitutions Yield a 140-fold Selective Melanocortin-3 Over Melanocortin-4 Receptor Agonist." ACS Med Chem Lett 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.